Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Vera Hars"'
Autor:
Koen van Besien, David D. Hurd, Kouros Owzar, Vera Hars, Thomas Martin, Edward A. Stadtmauer, Marcia Wilson, Charles A. Linker, Asad Bashey, Molly Boyd, Sarah A. Holstein, Ravi Vij, Teresa Gentile, Heather Landau, Mary M. Horowitz, Natalie S. Callander, Luis Isola, Philip L. McCarthy, Robert L. Schlossman, Parameswaran Hari, Scott E. Smith, Thomas C. Shea, Hani Hassoun, Jan S. Moreb, Daniel J. Weisdorf, Paul G. Richardson, Steven M. Devine, Kenneth C. Anderson, Marcelo C. Pasquini, Richard T. Maziarz, Craig C. Hofmeister, Muzaffar H. Qazilbash, Chelsea Schultz, Cesar Rodriguez, Brian McClune, Sin-Ho Jung, Chen Jiang, Sergio Giralt
Publikováno v:
The Lancet. Haematology
In the CALGB (Alliance) 100104 study, lenalidomide versus placebo after autologous stem-cell transplantation (ASCT) was investigated for patients with newly diagnosed myeloma. That study showed improved time to progression and overall survival and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5885770bf20d691c1eaaba4dba197a56
http://europepmc.org/articles/PMC5718627
http://europepmc.org/articles/PMC5718627
Autor:
Tsiporah B. Shore, Steven M. Devine, Kenneth R. Meehan, David D. Hurd, Jennifer Le-Rademacher, Thomas B. Shea, Vera Hars, Amanda F. Cashen, Kristina Laumann, Luis Isola, Frank V. Beardell, Sumithira Vasu, Kouros Owzar, M deMagalhaes-Silverman, Ravi Vij
Publikováno v:
Biol Blood Marrow Transplant
Relapse remains the major cause of death in older patients transplanted for acute myeloid leukemia (AML) in first complete remission or for patients with advanced myelodysplastic syndrome (MDS) at any age. Conventional myeloablative conditioning foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a33d556901383ff059957bcc6d64da2
https://europepmc.org/articles/PMC6790289/
https://europepmc.org/articles/PMC6790289/
Autor:
Thomas C. Shea, Maria R. Baer, Bayard L. Powell, Eva Hoke, Kati Maharry, Clara D. Bloomfield, Guido Marcucci, Wendy Stock, Steven L. Allen, Ravi Vij, Vera Hars, James W. Vardiman, Daniel J. DeAngelo, Richard A. Larson, Jonathan E. Kolitz, Stephen L. George
Publikováno v:
Blood. 116:1413-1421
Cancer and Leukemia Group B 19808 (CALGB 19808) is the only randomized trial of a second-generation P-glycoprotein (Pgp) modulator in untreated patients with acute myeloid leukemia (AML) younger than age 60 years. We randomly assigned 302 patients to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ea90b4b914459553f2f16c6d8f6ecf
https://doi.org/10.1182/blood-2009-07-229492
https://doi.org/10.1182/blood-2009-07-229492
Autor:
David L, Grinblatt, Daohai, Yu, Vera, Hars, James W, Vardiman, Bayard L, Powell, Sreenivasa, Nattam, Lewis R, Silverman, Carlos, de Castro, Richard M, Stone, Clara D, Bloomfield, Richard A, Larson, Scott, Wadler
Publikováno v:
Cancer. 115:84-93
BACKGROUD: The Cancer and Leukemia Group B evaluated oral topotecan administered at 2 schedules and doses for myelodysplastic syndrome (MDS). METHODS: Patients with previously untreated primary or therapy-related MDS were eligible. Patients with refr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e5c3c69a59a5668b7ce7b5302e251e
https://doi.org/10.1002/cncr.23995
https://doi.org/10.1002/cncr.23995
Autor:
Kathleen Donohue, Daniel J. DeAngelo, Thomas B. Shea, Wendy Stock, Richard A. Larson, Clara D. Bloomfield, Guido Marcucci, Vera Hars, Charles A. Linker, Richard Stone
Publikováno v:
Cancer Chemotherapy and Pharmacology. 63:859-864
Both homoharringtonine (HHT), an alkaloid derivative from the Chinese yew tree that inhibits protein synthesis, and low-dose cytarabine have independent activity in CML and have been used in combination after failure of interferon therapy.The CALGB p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226c0439bda40ceb4e8b91a41368d61c
https://doi.org/10.1007/s00280-008-0805-8
https://doi.org/10.1007/s00280-008-0805-8
Autor:
James L. Slack, Robert J. Soiffer, Steven M. Devine, Yi-Bin Chen, Richard Stone, Jack W. Hsu, Ravi Vij, Vera Hars, William Blum, Mary M. Horowitz, Thomas C. Shea, Charles A. Linker, Sergio Giralt, Edwin P. Alyea, Flora Mulkey, Alexander B. Sibley, Kouros Owzar, Richard E. Champlin, Richard A. Larson, Shelly L. Carter
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(35)
Purpose Long-term survival rates for older patients with newly diagnosed acute myeloid leukemia (AML) are extremely low. Previous observational studies suggest that allogeneic hematopoietic stem-cell transplantation (HSCT) may improve overall surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c064503524f94e06f36d2fd4dc306eb2
https://pubmed.ncbi.nlm.nih.gov/26527780
https://pubmed.ncbi.nlm.nih.gov/26527780
Autor:
Steve Devine, John Postiglione, S. Giralt, David D. Hurd, Thomas G. Martin, Kouros Owzar, Jan S. Moreb, Hani Hassoun, Vera Hars, Craig C. Hofmeister, KC Anderson, Edward A. Stadtmauer, Daniel J. Weisdorf, P. G. Richardson, Sarah A. Holstein, Nancy Callander, P.L. McCarthy, Chen Jiang, Ravi Vij, Marcelo C. Pasquini, Thomas C. Shea
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e61-e62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527bbd07896b09d31fd7182b8b58cd88
https://doi.org/10.1016/j.clml.2015.07.203
https://doi.org/10.1016/j.clml.2015.07.203
Autor:
Vera Hars, William J. Richtsmeier, Mary E. Albers, Andrew T. Huang, Leonard R. Prosnitz, Stephen L. George, Richard L. Scher, David M. Brizel, Samuel R. Fisher
Publikováno v:
New England Journal of Medicine. 338:1798-1804
Radiotherapy is often the primary treatment for advanced head and neck cancer, but the rates of locoregional recurrence are high and survival is poor. We investigated whether hyperfractionated irradiation plus concurrent chemotherapy (combined treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6559f6e09c6cdd2ee61dac2dbec86d
https://doi.org/10.1056/nejm199806183382503
https://doi.org/10.1056/nejm199806183382503
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 41:339-345
Purpose: This study was performed to investigate the feasibility of predicting survival in squamous cell carcinoma of the head and neck (SCCHN) with an artificial neural network (ANN), and to compare ANN performance with conventional models. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4f80cf168b3ee113b4d71840ac9dae
https://doi.org/10.1016/s0360-3016(98)00016-9
https://doi.org/10.1016/s0360-3016(98)00016-9
Autor:
Conaway, G McElveen, Barbara K. Rimer, Eric P. Winer, K. A. Havlin, Vera Hars, Wendy Demark-Wahnefried
Publikováno v:
The American Journal of Clinical Nutrition. 65:1495-1501
Weight gain, a common side effect among breast cancer patients receiving adjuvant chemotherapy, may decrease quality of life and impair survival. Weight gain during treatment is a well-known problem and has been studied by many investigators. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2cea59288f9ac78309722e970572285
https://doi.org/10.1093/ajcn/65.5.1495
https://doi.org/10.1093/ajcn/65.5.1495